Revvity | PKI - Operating Profit


Revvity reported $82.77M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Agilent USD 399M 46M Mar/2026
Align Technology USD 178.05M 46.66M Mar/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 53.9M 10M Dec/2025
Bruker USD 10.2M 66.1M Mar/2026
Celltrion KRW 12.9B 822.77M Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 32M 506M Mar/2026
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Divis Laboratories Ltd INR 8.14B 420M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Illumina USD 239M 17M Mar/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Laboratory Of America USD 410.1M 28.1M Mar/2026
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 233.93M 118M Mar/2026
Myriad Genetics USD -3M 20.3M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Ovoca Bio EUR -1.16M 4.48M Jun/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Pharma Mar EUR 622K 42.99M Mar/2026
Qiagen NV USD 121.88M 15.41M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Quidel USD -31.8M 5.5M Mar/2026
Repligen USD 19.98M 13K Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Sartorius EUR 160.7M 9.5M Mar/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Tilray USD -20.01M 9.34M Sep/2025
Waters USD 148M 122.52M Mar/2026
Zealand Pharma A/S -707.05M 245.73M Dec/2025
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026